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Abstract
Cloning is an important technique in functional genomics, particularly genetics and
molecular biology. Cloned genes can be used to facilitate protein expression; this is an essential
step in understanding gene function. In traditional cloning, the gene of interest is amplified and
tagged with a restriction enzyme sequence and ligated to the digested open vector. However, the
GATEWAY™ Cloning Technology provides a speedy and more efficient route to insert the gene
of interest in the desired vector, known as Destination vectors or Expression vectors, using sitespecific recombination sites and recombinase enzymes.1 Once DNA segments from the gene of
interest are cloned in the Entry vector (DONR Vector) by site-specific recombination, the vectors
can be used for research. This powerful system can easily transfer one or more DNA sequences
cloned in one Entry vector into multiple vectors in parallel reactions while maintaining orientation
and reading frame, which are clear benefits over the restriction enzyme cloning method (see
Figure1).2
Entry and Destination vectors used in the Gateway cloning system require storage by
transforming them into Escherichia coli strain DB3.1. They can replicate in this particular strain
because it is immune to the effects of the ccdB gene carried in the Gateway cassette; the cloning
strain is not resistant to the ccdB gene, so the empty vector does not survive in the cloning strain.
The ccdB gene cassette is replaced by the gene of interest (GOI) in the recombination step.
However, mutations in the ccdB gene can arise at low frequency, and these mutant plasmids (Entry
Vector) will consequently allow the growth of standard cloning strains of E. coli (e.g., DH5α).
Therefore, after making new Gateway plasmids stocks, the vector's ccdB gene mutants
must be tested. This process involves extracting the plasmid (vector) from a single DB3.1 bacterial
colony grown in LB media and transforming the plasmid into both DB3.1 and the preferred cloning
strain of E. coli DH5α in a controlled fashion. Only vector stocks that effectively kill the standard
cloning strain (i.e., no or few colonies are obtained after transformation) should be used in Gateway
cloning reactions.3 This process is called propagating gateway vectors. In this study, we
standardized protocol to propagate two Entry vectors (pDONR201 (Kanamycin resistant)) and
pDONR 207 (Gentamycin resistant)) and two destination vectors (pMDC32 (Overexpression) and
pMDC107 (GFP Tag expression)); both are kanamycin resistant. This standardized protocol will
be used in future laboratory work to produce a consistent method of Gateway vector propagation
specific to laboratory-specific needs.
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1
Introduction
Molecular cloning is a group of methods used in molecular biology with nearly countless
applications. The goal of molecular cloning is to isolate a DNA sequence, insert it into a host
organism, and produce perfect copies of that original sequence.4 In traditional molecular cloning
procedures, DNA fragments are inserted into the vector by restriction digestion and ligation and
transformed in the cloning strain, such as E. coli. Typically, the researcher isolates the desired
organisms' RNA and synthesizes cDNA. Then amplify the gene of interest (GOI) by polymerase
chain reaction and create specific restriction sites at the end to make an overhang. The researcher
will then cut open the vector or plasmid by restriction digestion to create overhangs on the vector.
The amplified GOI is then ligated to the linearized vector or plasmid by DNA ligase. Once the
cloned vector is ready, it is transformed into the cloning bacterial strain, such as E. coli DH5α, and
selected on the recommended antibiotic selection.5
The innovation of molecular cloning revolutionized the field of genetics as it allowed
researchers to study specific genes in previously inaccessible ways. Genes could be isolated and
analyzed to see their individual effects, which is nearly impossible to determine within the context
of complex organisms. However, the benefits of molecular cloning are not seen only in the
scientific community: its effects can be seen in day-to-day life. One of the most significant benefits
is the molecular cloning of insulin in E. coli to produce for diabetic patients.6 Such techniques
have also developed pathogen-resistant cotton and nutritionally fortified rice.7,8
Traditional cloning methods can be complex and challenging to perform and analyze
despite their many benefits. In the late 1990s, a new cloning system, Gateway cloning, was
developed, which can efficiently transfer genes of interest between plasmids using a set of
recombination sequences, the "Gateway att" sites, and two recombinase enzyme mixes, called "LR
Clonase," and "BP Clonase." While it is more costly than traditional cloning, it saves time overall,
its applications are more widespread, and its results are more straightforward.9 The cloning process
can be split into two general steps: the BP and LR reactions. Gateway cloning begins with adding
attB1 and attB2 sequences to the ends of the gene fragment desired for cloning through PCR
amplification. These PCR products are then mixed with the “entry vector” having compatible att
sites (P sites) and BP enzyme mix, which facilitates the insertion of the gene of interest into the
plasmid. This product is then considered an “entry clone” and is transformed into a cloning strain,
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such as E. coli DH5α, and selected based on the recommended antibiotic for that entry vector. The
second step of the Gateway cloning process, the LR reaction, consists of sequencing the entry
clone and transferring the GOI to the destination vector for gene expression by using the LR
clonase enzyme. The destination clone is then transformed into the cloning strain, such as E.
coli DH5α, and selected according to the appropriate antibiotic. Once the destination vector
contains the gene of interest, it is considered an “expression clone.”10
Both the entry and destination vectors contain the ccdB gene that is switched out with the
gene of interest. Thus, the entry/expression clone includes the gene of interest, and the by-product
contains the ccdB gene. The ccdB gene produces the ccdB toxin, which is fatal to bacterial cells.
It ensures that any cells containing either by-products or unsuccessfully cloned vectors will die,
leaving only successful clones behind. For long-term storage, the vectors are stored in E. coli
DB3.1, which is resistant to the ccdB toxin and can thus survive the presence of vectors containing
the ccdB gene.11 Over time, naturally occurring mutations in the ccdB gene will cause the toxic
selection feature to be ineffective, but it can be difficult to discern because the vectors are stored
in a ccdB resistant strain. Therefore, it is essential to have a protocol to test for ccdB mutation
regularly and subsequently remove the ccdB mutants. This process is called “propagation.”12 The
goal of this project was to develop a standardized propagation protocol for use in the laboratory.
In this study, we standardized protocol to propagate two Entry vectors (pDONR201
(Kanamycin resistant) and pDONR207 (Gentamycin resistant)) and two destination vectors
(pMDC32 (Overexpression) and pMDC107 (GFP Tag expression)); both are kanamycin resistant.
This standardized protocol will be used in future laboratory work to produce a consistent method
of Gateway vector propagation suited for laboratory-specific needs.
Methods
Plasmid Extraction
The Gateway vectors selected for testing must first be extracted from the DB3.1 glycerol
stock. The bacterial strain E. coli DB3.1 containing the plasmid was first streaked on an LB agar
plate with plasmid-specific antibiotics added. The LB plate was then incubated at 37°C overnight.
After incubation, a single colony was inoculated into 5ml of LB broth, again with the appropriate
antibiotic added. Chloramphenicol was also added at a concentration of 33μg/ml to create a high
copy number of plasmids (the chloramphenicol inhibits the replication of genomic DNA and
enriches plasmids). The LB broth was then incubated overnight at 37°C.
The bacterial culture was then centrifuged for one minute at 12,000 rpm to pellet the
bacteria. The supernatant was removed, and the pelleted bacteria were resuspended in 250µl of
Solution I before being transferred to a microcentrifuge tube (The recipe for Solution I can be
found at the end of the protocol). Solution I contains EDTA, glucose, and Tris, which protect the

10

Xu, R., & Qingshun, L. (2008). Protocol: Streamline cloning of genes into binary vectors in Agrobacterium via the
Gateway® TOPO vector system. Plant Methods, 4(1). doi: 10.1186/1746-4811-4-4
11

Gateway® recombinational cloning: a biological operating system. (2022). Expert Opinion On Drug Discovery.
Retrieved from https://www.tandfonline.com/doi/full/10.1517/17460441.2.4.571?scroll=top&needAccess=true
12

Reece-Hoyes, J., & Walhout, A. (2018). Propagating Gateway Vectors. Cold Spring Harbor Protocols, 2018(1),
pdb.prot094920. doi: 10.1101/pdb.prot094920

3
DNA from degradation, maintain a constant pH, and increase osmotic pressure outside the cells.
RNase was also added to Solution I before its addition to the bacterial pellet.
Next, 250µl of Solution II was added and mixed in by inverting the microcentrifuge tube
4-6 times (The recipe for Solution II can be found at the end of the protocol). Solution II contains
NaOH, which ruptures the cells, and SDS, a detergent that degrades lipid membranes and makes
proteins within the cells more soluble. The solution in the microcentrifuge tube was mixed until
it became slightly transparent and viscous. The mixture was incubated at room temperature for
not more than 5 mins, after which 350µl of Solution III was added to the microcentrifuge tube
and mixed in by inverting the tube 4-6 times (The recipe for Solution III can be found at the end
of the protocol). Solution III consists of potassium acetate and glacial acetic acid. The potassium
acetate causes the SDS from Solution II and other cellular debris to precipitate. The glacial acetic
acid neutralizes the pH (balancing out the NaOH in Solution II); this allows the DNA strands to
reform from their previously denatured state. The tube was inverted up to 10 times until the
solution became cloudy, after which it was centrifuged at 13,000 rpm for 10 minutes. White
pellet formation was confirmed before proceeding to the next step.
The supernatant (800µl) was collected, and 100µl of isopropanol was added. The mixture
was then loaded into a spin column. The spin column was allowed to sit at room temperature for
one minute and then centrifuged for one minute at 13,000 rpm. The flow-through was transferred
into a fresh tube with 700µl of ice-cold ethanol mix and kept at -20°C overnight.
750µl of 70% ethanol was added to the spin column and centrifuged for 1 minute at 13,000
rpm to wash the spin column. The flow-through was discarded, and the spin column was
centrifuged again for another 2 minutes to remove any residual ethanol. The spin-column was then
transferred to a clean 1.5ml microcentrifuge tube, and 30µl nuclease-free water was added to elute
the DNA. The column was allowed to stand for 5 minutes and then centrifuged for 1 minute. After
that, the Nanodrop was used to determine the DNA concentration; the DNA was then diluted to
the attention of 100ng/µl.
o Procedure for additional step:
▪ Centrifuge for 10 minutes at 13,000 rpm (~17,900 x g) in a tabletop microcentrifuge.
▪ Discard the supernatant and add 750µl of 70% ethanol—centrifuge
for 10 minutes at 13,000 rpm.
▪ Discard the supernatant and dry pellet by tapping down on a paper
towel.
▪ Resuspend pellet in 50µl of water.
▪ Nanodrop.
Chemical Competent Cell Preparation
Chemically competent cells are needed in the plasmid transformation step, so they were
prepared ahead of time by inoculating a liquid overnight culture of the desired bacteria in 250ml
LB broth (this procedure was performed for both E. coli DB3.1 and E. coli DH5α). The culture
was incubated at 37°C until the OD600nm was between 0.35 and 0.4 (checked using a spectrometer),
after which the flasks containing the liquid cultures was placed on ice to chill the bacteria.
250ml of the culture was then placed into ice-cold centrifuge tubes and centrifuged at
3000g (~4000 rpm) for 15 minutes at 4°C (Spin #1). The supernatant was decanted and the pellet
resuspended in 25ml ice-cold CaCl2 before being centrifuged at 2000g (~3000 rpm) for 15 minutes
at 4°C (Spin #2). The supernatant was again decanted before the pellet was resuspended in 50ml
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ice-cold CaCl2 and kept on ice for 20 minutes. The bacteria were centrifuged at 2000g (~3000
rpm) for 15 minutes for 15 minutes at 4°C (Spin #3).
Following the third spin, the supernatant was again decanted, and the pellet was
resuspended in 15ml ice-cold 85 mM CaCl2 with 15% glycerol. The bacterial culture was then
spun again at 1000g (~2000 rpm) for 15 minutes at 4°C (Spin #4). The supernatant was again
decanted and the pellet resuspended in 500µl ice-cold 85 mM CaCl2 with 15% glycerol. The
bacterial culture was then stored in pre-chilled 1.5 ml sterile tubes (50µl per tube); the tubes were
then stored at -80°C.
Plasmid Transformation
The heat-shock method was used to transform the plasmids into the desired bacterial
strains. First 1µl of the 100ng/µl plasmid (from plasmid extraction) was mixed into 25µl of both
E. coli DB3.1 (a storage strain) and E. coli DH5α (a cloning strain) chemically competent cells
and then kept on ice for 30 minutes. Next, the tubes containing the bacteria-plasmid mixture were
immersed in a 42°C water bath for 30 seconds, after which they were immediately put back on the
ice for 2 minutes. Once the 2 minutes passed, 200µl of SOC media was added (The recipe for SOC
can be found at the end of the protocol). The heat-shock treatment creates pores on the competent
bacterial cells for plasmid intake. This process can be very stressful for bacteria; thus, SOC media
is added to help the bacterial cells recover. The bacteria were then incubated on the shaker for one
hour at 37°C to recover from the heat shock.
After incubation, 100µl of the transformed DB3.1 and DH5α strains were plated on LB
agar with the appropriate antibiotic added. The plates were then incubated overnight at 37°C and
checked for growth the next day. Because the plasmids that entered the bacterial cells during the
transformation step still have the ccdB gene, if no mutation within that gene has occurred, we can
expect growth on the DB3.1 plate (because the DB3.1 strain is ccdB toxin-resistant) and no growth
on the DH5α plate (because DH5α is not resistant to the ccdB toxin).
Because there was growth on the DH5α plate (indicating that mutated plasmids were in
those bacteria that did grow), two colonies were selected from the DB3.1 plate (which may or may
not include mutated plasmids) and inoculated. The plasmid extraction and transformation steps
were repeated until very few colonies appeared on the DH5α plate, indicating that there were very
few mutations present within that bacterial selection.
Once colony growth in the cloning strain was reduced enough or entirely, the plasmids
were stored in E. coli DB3.1 as a glycerol stock, ready for use in Gateway cloning experiments.
This overall process was repeated multiple times on four different Gateway vectors until a clear
enough protocol was developed for later use by researchers in the laboratory.
Maintenance of Bacterial Cultures
The purified plasmids were stored in bacteria as a glycerol stock (1 ml of overnight
grown bacteria in 1 ml of 50% sterilized glycerol stored in cryogenic 2 ml tubes in a -80°C
freezer).
Results and Conclusion
Once the process of gateway vector propagation was carried out successfully to ensure a
thorough comprehension of each step, the protocol was carefully recorded in simple and
straightforward terms (see appendix). This document will be handy in future laboratory work, as
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previously, the instructions for the carrying out of propagation were not all collected in one
place. Now that there is a step-by-step centralized protocol for researchers to follow. The lack of
a streamlined protocol document made it difficult to know the purpose of the work and predict
what should be done next; from a new researcher’s standpoint, the process seemed like a series
of random steps with no real goal in sight. This lack of standardized protocol also caused a
reliance on the more senior laboratory members to guide newcomers through each step of the
propagation process and contextualize the work for the newcomers’ understanding. The
laboratory members who are newer to laboratory work will be better able to orient themselves
within the basic layout of the Gateway vector propagation procedure. Perhaps more importantly,
they will be able to foster independence early on in their laboratory work.
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Reflection
This capstone project significantly impacted my undergraduate university experience.
Standardizing the protocol for gateway vector propagation stretched me much more and in many
more ways than I had initially anticipated. I would not be nearly as confident in my abilities as I
am today had I not undergone this enormous undertaking. I have found that I am much more
prepared for my future after completing this task.
The most significant benefit to come out of my Honors capstone is my relationship with
my mentor. It was my first experience in a laboratory where I was the main person working on a
particular project. I relied a lot on Dr. Kaundal to guide me through the steps and procedures
until I could do more independently. We met, at the minimum, weekly, and often we met even
more frequently. Dr. Kaundal was always willing to re-explain anything that was still elusive to
me, and I felt comfortable coming to her with questions and concerns. She has been so patient
and encouraging, and she pushes me to perform as well as she knows I can; she has also assisted
me in my applications for graduate programs, and I know her work with me has prepared me for
such future goals better than anything else I have experienced. Dr. Kaundal has taught me
countless skills both in and outside of the laboratory setting, and I will forever be grateful for her
example as a compassionate mentor.
Standardizing the protocol for propagating gateway vectors has been an excellent
capstone project for my undergraduate experience at Utah State University. Understanding how
gateway vectors function requires a deep understanding of genetics and cloning; to do so, I had
to both rely on knowledge gained throughout my courses and dive deeper into research outside
my typical coursework. Because this research was in the context of plant genetics, I also had to
broaden my knowledge in this field to understand how everything works together contextually.
Truthfully, these concepts took me a lot of time and effort to grasp; it wasn’t until I combined
understanding from my courses, my independent research, and discussions with my mentor that
comprehension finally started to dawn on me. This process brought together numerous aspects of
my education, both inside and outside the classroom. It helped me better understand how
seemingly isolated concepts actually interact and work together in real life. Through the
challenge of understanding how the concepts of vector genetics connect with the laboratory
procedures, I also developed resilience in learning ideas that are not immediately clear to me. It
could be frustrating after having something explained or looked up after so many times, still
having difficulty grasping the concepts. Still, I learned how to push through that frustration to
keep working and trying new learning methods until I finally understood enough to continue.
This capstone project has also exceptionally prepared me for my future educational and
career goals. As mentioned, I am currently applying to graduate programs, and I know that the
research I have performed for this project has been an asset to me and something that sets me
apart in my applications. The technical skills that I have developed are also beneficial; these
projects are not rare in genetics and molecular biology. The abilities that I have gained will be
widely transferable to future careers and positions.
A considerable complication in completing this project, as I am sure is common to many
projects, was the arrival of COVID-19 and all of the rippling effects that the pandemic has had
on on-campus activities. Between COVID-19, related mental health difficulties, and summers
spent out of the state, it was a long haul to get this project done. When classes first went online,
we paused laboratory work indefinitely; it was an adjustment phase. From there, I came in
whenever I could, but often the semesters were so chaotic that I could only get to work on one
vector at a time. Usually, after an extended break, I would have to learn things almost from
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scratch again and go back through the entire process of remembering concepts and relearning
techniques. This could also be highly frustrating for me; I felt like once I had learned something,
I should not have to relearn it a second or third, or fourth time. However, after a while, I learned
to give myself some grace; everyone needs to freshen up their memory on specific topics, even
when they are experts in that field. It was another excellent exercise in patience for me and
something that will help me as I continue my education into graduate school and beyond.
Another aspect of my capstone project that I particularly enjoyed was working with many
people. Dr. Kaundal often brings new undergraduates into her laboratory. At the start of their
work, she usually has them jump in on gateway vector propagation. It provides an excellent
introduction to many transferrable techniques across most of our laboratory activities. As I
worked on this project for multiple semesters, I got to work with nearly every undergraduate and
graduate student that came into our laboratory. Each individual that joined our laboratory group
was unique, with their background and career goals, and each person brought something
different to the table. I learned various things from each person that I had the privilege of
working with, and without this project is my main focus for so long, I wouldn’t have had that
opportunity. Having this background of working with so many different people has also helped
me focus on the end goal of my capstone: to set up a consistent protocol for each person to
follow to get consistent results from the procedure. Understanding how so many different people
performed in the laboratory informed how I set up my standardized protocol. Each step that
invited hesitation for somebody was a step I made sure to include extra clarification on.
Overall, this capstone was one of the highlights of my undergraduate career and my
Honors experience. Standardizing the gateway vector propagation procedure tied in so many
different aspects of my university education, and I developed relationships that will bolster me
for years to come. I am so pleased with my final product and thrilled that it will help lab
members throughout the foreseeable future.
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Appendix

Figure 1 A) Traditional cloning vs. Gateway cloning to clone a gene of interest (GOI) in the
Entry Vector. B) Gateway cloning to use Entry vector to transfer GOI into different Destination
vectors (Expression Vector) such as pMDC32 (Overexpression), pMDC107
Standardized Protocol for the Propagation of Gateway Vectors
Following the preparation of new Gateway plasmid stocks, it is necessary to test their
ability to grow in cloning strains to ensure that mutated plasmids are not preserved. The
following protocol has been standardized for Dr. Amita Kaundal’s research laboratory and will
guide the propagation process of Entry vectors (pDONR201 (Kanamycin resistant)) and pDONR
207 (Gentamycin resistant)) and two destination vectors (pMDC32 (Overexpression) and
pMDC107 (GFP Tag expression)); both are kanamycin resistant.
1) Propagation of pDONR201
1
2.
3.
4.
5.
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Streak bacteria strain E. coli DB3.1 containing pDONR201 from the glycerol
stock onto an LB plate containing the Kanamycin 50µg/ml and grow at 37°C
overnight.
Inoculate a single colony from the LB plate into 5ml of LB broth with the
Kanamycin 50µg/ml and add chloramphenicol at a concentration of 33μg/ml
concentration. Grow overnight at 37°C in a shaker incubator.
Isolate plasmid using alkaline lysis method by Birnboim et al. 1979.13 described
in the method section.
Transform 100ng of the plasmid into chemically competent E. coli DB3.1 and E.
coli DH5α cells and plate 100µl of the transformed mixture on LB agar media
containing Kanamycin 50µg/ml.
Observe the growth of both strains after incubating overnight at 37°C.

Birnboim, H., & Doly, J. (1979). A rapid alkaline extraction procedure for screening recombinant plasmid
DNA. Nucleic Acids Research, 7(6), 1513-1523. doi: 10.1093/nar/7.6.1513
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6. If the colonies appeared for E. coli DH5α then select two colonies from the E.
coli DB3.1 and inoculate separately in LB broth media containing Kanamycin
50µg/ml and chloramphenicol 33μg/ml and repeat steps 2-5 until no or very few
colonies appear on E. coli DH5α plates.
7. Once, few or no colonies appear on LB plates with E. coli DH5α (indicating that
mutated plasmids are minimal). Save the colony from E. coli DB3.1, which
showed no growth in E. coli DH5α, and store it as a glycerol stock at -80oC.

14

2

Propagation of pDONR207
1 Streak bacteria strain E. coli DB3.1 containing pDONR207 from the glycerol
stock onto an LB plate containing the Gentamycin 15µg/ml and grow at 37°C
overnight.
2 Inoculate a single colony from the LB plate into 5ml of LB broth with the
Gentamycin 15µg/ml and add chloramphenicol at a concentration of 33μg/ml
concentration. Grow overnight at 37°C in a shaker incubator.
3 Isolate plasmid using alkaline lysis method by Birnboim et al. 1979.14
described in the method section.
4 Transform 100ng of the plasmid into chemically competent E. coli DB3.1 and
E. coli DH5α cells and plate 100µl of the transformed mixture on LB agar
media containing Gentamycin 15µg/ml.
5 Observe the growth of both strains after incubating overnight at 37°C.
6 If the colonies appeared for E. coli DH5α then select two colonies from the E.
coli DB3.1 and inoculate separately in LB broth media containing
Gentamycin 15µg/ml and chloramphenicol 33μg/ml and repeat steps 2-5 until
no or very few colonies appear on E. coli DH5α plates.
7 Once, few or no colonies appear on LB plates with E. coli DH5α (indicating
that mutated plasmids are minimal). Save the colony from E. coli DB3.1,
which showed no growth in E. coli DH5α, and store it as a glycerol stock at 80oC.

3

Propagation of pMDC32 and pMDC107
These destination vectors are resistant to Kanamycin, so the propagation
protocol standardized for pDONR201 can be followed for these vectors.

Birnboim, H., & Doly, J. (1979). A rapid alkaline extraction procedure for screening recombinant plasmid
DNA. Nucleic Acids Research, 7(6), 1513-1523. doi: 10.1093/nar/7.6.1513
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Recipes:
1) Plasmid preparation solutions
• Solution I
• 50mM Tris pH 8.0 with HCl
• 10mM EDTA
• 100ug/ml RNase A
• Solution II
• 200mM NaOH
• 1% SDS
• Solution III
• 3.0M Potassium Acetate, pH5.5
For 1 liter: Dissolve 294.5g potassium acetate in 500ml of H2O. Adjust
the pH to 5.5 with glacial acetic acid (~110ml). Adjust the volume to 1
liter with ddH2O.
• TE
• 10mM Tris pH 8.0 with HCl
• 1mM EDTA
2) SOC media
• ~800 mL distilled water
• 5g yeast extract
• 20g tryptone
• 0.584g NaCl
• 0.186g KCl
• 2.4g MgSO4
Bring final volume to 1 L with distilled water
• Add 20 ml filter-sterilized 20% glucose solution
Autoclave
3) LB agar media
To make 1L:
• 20 g agar
• 10 g NaCl
• 10 g tryptone
• 5 g yeast extract
• Add distilled water to bring the final volume to 1 L
Adjust pH to 7.0 using 5 M NaOH
Autoclave
4) Antibiotic stocks
• Kanamycin: 50mg/ml
• Weigh 50 mg of powder in a 1.7 ml tube and dissolve in 1 ml sterilized water
• Gentamycin 15mg/ml
• Weigh 15 mg of powder in a 1.7 ml tube and dissolve in 1 ml sterilized water
• Chloramphenicol 25mg/ml
• Weigh 25 mg of powder in a 1.7 ml tube and dissolve in 1 ml ethanol
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